Clinical Trial: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Solid Tumors With HRAS Alterations
Study Type: INTERVENTIONAL
Official Title: Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of KO-2806 When Administered as Mono
Brief Summary:
This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyl transferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.
Read more